Literature DB >> 28344318

Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm.

K Suzuki1, Y Suzuki2, A Hama1, H Muramatsu1, M Nakatochi3, M Gunji4, D Ichikawa1, M Hamada1, R Taniguchi1, S Kataoka1, N Murakami1, D Kojima1, Y Sekiya1, E Nishikawa1, N Kawashima1, A Narita1, N Nishio1,3, Y Nakazawa5, H Iwafuchi6, K-I Watanabe7, Y Takahashi1, M Ito4, S Kojima1, S Kato2, Y Okuno3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28344318     DOI： 10.1038/leu.2017.101

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb.

Authors:  F Liu; W Lei; J P O'Rourke; S A Ness
Journal:  Oncogene       Date:  2006-02-02       Impact factor: 9.867

2.  Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

Authors:  M R Sapienza; F Fuligni; C Agostinelli; C Tripodo; S Righi; M A Laginestra; A Pileri; M Mancini; M Rossi; F Ricci; A Gazzola; F Melle; C Mannu; F Ulbar; M Arpinati; M Paulli; T Maeda; D Gibellini; L Pagano; N Pimpinelli; M Santucci; L Cerroni; C M Croce; F Facchetti; P P Piccaluga; S A Pileri
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

3.  Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.

Authors:  J Menezes; F Acquadro; M Wiseman; G Gómez-López; R N Salgado; J G Talavera-Casañas; I Buño; J V Cervera; S Montes-Moreno; J M Hernández-Rivas; R Ayala; M J Calasanz; M J Larrayoz; L F Brichs; M Gonzalez-Vicent; D G Pisano; M A Piris; S Álvarez; J C Cigudosa
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

4.  CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

Authors:  Dominique Leroux; Francine Mugneret; Mary Callanan; Isabelle Radford-Weiss; Nicole Dastugue; Jean Feuillard; Franseza Le Mée; Ghislaine Plessis; Pascaline Talmant; Nathalie Gachard; Françoise Uettwiller; Marie-Pierre Pages; Marie-Joëlle Mozziconacci; Virginie Eclache; Catherine Sibille; Hervé Avet-Loiseau; Marina Lafage-Pochitaloff
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

5.  Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation.

Authors:  Damien Roos-Weil; Sascha Dietrich; Ariane Boumendil; Emmanuelle Polge; Dominique Bron; Enric Carreras; Arturo Iriondo Atienza; William Arcese; Dietrich W Beelen; Jan J Cornelissen; Nicolaus Kröger; Giuseppe Milone; Giuseppe Rossi; Fabrice Jardin; Christina Peters; Vanderson Rocha; Anna Sureda; Mohamad Mohty; Peter Dreger
Journal:  Blood       Date:  2012-11-30       Impact factor: 22.113

Review 6.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

7.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

8.  Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas.

Authors:  G L Shen-Ong; M Potter; J F Mushinski; S Lavu; E P Reddy
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

Review 9.  Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.

Authors:  Livio Pagano; Caterina G Valentini; Sara Grammatico; Alessandro Pulsoni
Journal:  Br J Haematol       Date:  2016-06-05       Impact factor: 6.998

10.  Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile.

Authors:  Lourdes Martín-Martín; Antonio López; Belén Vidriales; María Dolores Caballero; António Silva Rodrigues; Silvia Inês Ferreira; Margarida Lima; Sérgio Almeida; Berta Valverde; Pilar Martínez; Ana Ferrer; Jorge Candeias; Francisco Ruíz-Cabello; Josefa Marco Buadesa; Amparo Sempere; Neus Villamor; Alberto Orfao; Julia Almeida
Journal:  Oncotarget       Date:  2015-08-07
View more
  13 in total

1.  Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis.

Authors:  Sakurako Suma; Mamiko Sakata-Yanagimoto; Tran B Nguyen; Keiichiro Hattori; Taiki Sato; Masayuki Noguchi; Yasuhito Nannya; Seishi Ogawa; Rei Watanabe; Manabu Fujimoto; Naoya Nakamura; Manabu Kusakabe; Hidekazu Nishikii; Takayasu Kato; Shigeru Chiba
Journal:  Int J Hematol       Date:  2018-04-28       Impact factor: 2.490

2.  Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

Authors:  Annika K Wefers; Damian Stichel; Daniel Schrimpf; Roland Coras; Mélanie Pages; Arnault Tauziède-Espariat; Pascale Varlet; Daniel Schwarz; Figen Söylemezoglu; Ute Pohl; José Pimentel; Jochen Meyer; Ekkehard Hewer; Anna Japp; Abhijit Joshi; David E Reuss; Annekathrin Reinhardt; Philipp Sievers; M Belén Casalini; Azadeh Ebrahimi; Kristin Huang; Christian Koelsche; Hu Liang Low; Olinda Rebelo; Dina Marnoto; Albert J Becker; Ori Staszewski; Michel Mittelbronn; Martin Hasselblatt; Jens Schittenhelm; Edmund Cheesman; Ricardo Santos de Oliveira; Rosane Gomes P Queiroz; Elvis Terci Valera; Volkmar H Hans; Andrey Korshunov; Adriana Olar; Keith L Ligon; Stefan M Pfister; Zane Jaunmuktane; Sebastian Brandner; Ruth G Tatevossian; David W Ellison; Thomas S Jacques; Mrinalini Honavar; Eleonora Aronica; Maria Thom; Felix Sahm; Andreas von Deimling; David T W Jones; Ingmar Blumcke; David Capper
Journal:  Acta Neuropathol       Date:  2019-09-28       Impact factor: 17.088

3.  How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Authors:  Francine Garnache-Ottou; Chrystelle Vidal; Sabeha Biichlé; Florian Renosi; Eve Poret; Maïder Pagadoy; Maxime Desmarets; Anne Roggy; Estelle Seilles; Lou Soret; Françoise Schillinger; Sandrine Puyraimond; Tony Petrella; Claude Preudhomme; Christophe Roumier; Elisabeth A MacIntyre; Véronique Harrivel; Yohan Desbrosses; Bérengère Gruson; Franck Geneviève; Sylvain Thepot; Yuriy Drebit; Thibaut Leguay; François-Xavier Gros; Nicolas Lechevalier; Pascale Saussoy; Véronique Salaun; Edouard Cornet; Zehaira Benseddik; Richard Veyrat-Masson; Orianne Wagner-Ballon; Célia Salanoubat; Marc Maynadié; Julien Guy; Denis Caillot; Marie-Christine Jacob; Jean-Yves Cahn; Rémy Gressin; Johann Rose; Bruno Quesnel; Estelle Guerin; Franck Trimoreau; Jean Feuillard; Marie-Pierre Gourin; Adriana Plesa; Lucile Baseggio; Isabelle Arnoux; Norbert Vey; Didier Blaise; Romaric Lacroix; Christine Arnoulet; Blandine Benet; Véronique Dorvaux; Caroline Bret; Bernard Drenou; Agathe Debliquis; Véronique Latger-Cannard; Caroline Bonmati; Marie-Christine Bene; Pierre Peterlin; Michel Ticchioni; Pierre-Simon Rohrlich; Anne Arnaud; Stefan Wickenhauser; Valérie Bardet; Sabine Brechignac; Benjamin Papoular; Victoria Raggueneau; Jacques Vargaftig; Rémi Letestu; Daniel Lusina; Thorsten Braun; Vincent Foissaud; Jérôme Tamburini; Hind Bennani; Nicolas Freynet; Catherine Cordonnier; Magali Le Garff-Tavernier; Nathalie Jacques; Karim Maloum; Damien Roos-Weil; Didier Bouscary; Vahid Asnafi; Ludovic Lhermitte; Felipe Suarez; Etienne Lengline; Frédéric Féger; Giorgia Battipaglia; Mohamad Mohty; Sabrina Bouyer; Ouda Ghoual; Elodie Dindinaud; Caroline Basle; Mathieu Puyade; Carinne Lafon; Thierry Fest; Mikael Roussel; Xavier Cahu; Elsa Bera; Sylvie Daliphard; Fabrice Jardin; Lydia Campos; Françoise Solly; Denis Guyotat; Anne-Cécile Galoisy; Alice Eischen; Caroline Mayeur-Rousse; Blandine Guffroy; Christian Recher; Marie Loosveld; Alice Garnier; Vincent Barlogis; Maria Alessandra Rosenthal; Sophie Brun; Nathalie Contentin; Sébastien Maury; Mary Callanan; Christine Lefebvre; Natacha Maillard; Patricia Okamba; Christophe Ferrand; Olivier Adotevi; Philippe Saas; Fanny Angelot-Delettre; Delphine Binda; Eric Deconinck
Journal:  Blood Adv       Date:  2019-12-23

4.  Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis.

Authors:  Florian Renosi; Anne Roggy; Ambre Giguelay; Lou Soret; Pierre-Julien Viailly; Meyling Cheok; Sabeha Biichle; Fanny Angelot-Delettre; Vahid Asnafi; Elizabeth Macintyre; Sandrine Geffroy; Mary Callanan; Tony Petrella; Eric Deconinck; Etienne Daguindau; Véronique Harrivel; Sabrina Bouyer; Véronique Salaun; Pascale Saussoy; Jean Feuillard; Pascal Fuseau; Philippe Saas; Olivier Adotévi; Fabrice Jardin; Christophe Ferrand; Claude Preudhomme; Jacques Colinge; Christophe Roumier; Francine Garnache-Ottou
Journal:  Blood Adv       Date:  2021-03-09

5.  Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark.

Authors:  Justin Taylor; Michael Haddadin; Vivek A Upadhyay; Erwin Grussie; Neha Mehta-Shah; Andrew M Brunner; Abner Louissaint; Scott B Lovitch; Ahmet Dogan; Amir T Fathi; Richard M Stone; Martin S Tallman; Raajit K Rampal; Donna S Neuberg; Kristen E Stevenson; Steven M Horwitz; Andrew A Lane
Journal:  Blood       Date:  2019-06-26       Impact factor: 22.113

6.  Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.

Authors:  Sumiko Takao; Lauren Forbes; Masahiro Uni; Shuyuan Cheng; Jose Mario Bello Pineda; Yusuke Tarumoto; Paolo Cifani; Gerard Minuesa; Celine Chen; Michael G Kharas; Robert K Bradley; Christopher R Vakoc; Richard P Koche; Alex Kentsis
Journal:  Elife       Date:  2021-02-02       Impact factor: 8.713

7.  Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms.

Authors:  Mrinal M Patnaik; Terra Lasho; Matthew Howard; Christy Finke; Rhett L Ketterling; Aref Al-Kali; Animesh Pardanani; Nathalie Droin; Naseema Gangat; Ayalew Tefferi; Eric Solary
Journal:  Blood Cancer J       Date:  2018-08-22       Impact factor: 11.037

8.  Blastic Plasmacytoid Dendritic Cell Neoplasm: First Case Report From Rwanda and Review of the Literature.

Authors:  Deogratias Ruhangaza; Marcellin C Mugabe; Catherine N Kigonya; Andrew A Lane; Elizabeth A Morgan
Journal:  J Glob Oncol       Date:  2019-06

9.  Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.

Authors:  Armando N Bastidas Torres; Davy Cats; Hailiang Mei; Daniele Fanoni; Jessica Gliozzo; Laura Corti; Marco Paulli; Maarten H Vermeer; Rein Willemze; Emilio Berti; Cornelis P Tensen
Journal:  Genes Chromosomes Cancer       Date:  2019-12-31       Impact factor: 5.006

10.  Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report.

Authors:  Solomiya Grushchak; Cossette Joy; Arielle Gray; Dan Opel; Jodi Speiser; Jeave Reserva; Rebecca Tung; Scott E Smith
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.